carbon monoxide has been researched along with prednisolone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishizuka, S; Monma, M; Sasaki, H; Sekizawa, K; Yamara, M; Yamaya, M | 1 |
| Beretta, L; Caronni, M; Origgi, L; Ponti, A; Raimondi, M; Scorza, R; Viscuso, T | 1 |
| Bambery, P; Sharma, A; Sharma, S; Suryanaryana, BS; Wanchu, A | 1 |
| Chang, DV; Ehsan, Z; Kisling, J; Montgomery, GS; Tepper, RS; Tiller, C | 1 |
| Fiddler, CA; Parfrey, H; Simler, N; Thillai, M | 1 |
2 trial(s) available for carbon monoxide and prednisolone
| Article | Year |
|---|---|
Oral cyclophosphamide improves pulmonary function in scleroderma patients with fibrosing alveolitis: experience in one centre.
Topics: Administration, Oral; Breath Tests; Carbon Monoxide; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Pulmonary Diffusing Capacity; Pulmonary Fibrosis; Respiratory Function Tests; Scleroderma, Systemic; Vital Capacity | 2007 |
High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.
Topics: Adult; Carbon Monoxide; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Prednisolone; Prospective Studies; Pulse Therapy, Drug; Scleroderma, Systemic; Treatment Outcome; Vital Capacity | 2009 |
3 other study(ies) available for carbon monoxide and prednisolone
| Article | Year |
|---|---|
Exhaled carbon monoxide levels during treatment of acute asthma.
Topics: Administration, Inhalation; Administration, Oral; Anti-Asthmatic Agents; Asthma; Breath Tests; Carbon Monoxide; Female; Glucocorticoids; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Prednisolone; Time Factors | 1999 |
An infant with pulmonary interstitial glycogenosis: clinical improvement is associated with improvement in the pulmonary diffusion capacity.
Topics: Breath Tests; Carbon Monoxide; Disease Progression; Forced Expiratory Volume; Glucocorticoids; Glycogen Storage Disease; Humans; Infant; Lung; Lung Diseases, Interstitial; Male; Prednisolone; Pulmonary Diffusing Capacity; Tomography, X-Ray Computed; Vital Capacity | 2014 |
Use of mycophenolate mofetil and azathioprine for the treatment of chronic hypersensitivity pneumonitis-A single-centre experience.
Topics: Adrenal Cortex Hormones; Aged; Alveolitis, Extrinsic Allergic; Azathioprine; Carbon Monoxide; Chronic Disease; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Pulmonary Diffusing Capacity; Respiratory Function Tests; Retrospective Studies; Vital Capacity | 2019 |